Loading clinical trials...
Loading clinical trials...
Pharmacokinetics of Tirzepatide Following Administration to Subjects With Impaired Renal Function
Conditions
Interventions
Tirzepatide
Locations
4
United States
Orange County Research Center
Tustin, California, United States
Clinical Pharmacology of Miami
Miami, Florida, United States
Orlando Clinical Research Center
Orlando, Florida, United States
High Point Clinical Trials Center
High Point, North Carolina, United States
Start Date
March 30, 2018
Primary Completion Date
August 19, 2019
Completion Date
August 19, 2019
Last Updated
March 23, 2023
NCT07262333
NCT01524276
NCT07146854
NCT04163614
NCT04580420
NCT06190717
Lead Sponsor
Eli Lilly and Company
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions